Trial
NCT04025216
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Kite, A Gilead Company
Collaborators
—
Condition
Non-Small Cell Lung Cancer
Intervention
CART-TnMUC1
Why stopped
The sponsor finds the risk/benefit analysis unfavorable and has terminated the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-24